SCHEMBL430876

SCHEMBL430876

CCCC(CCC)OC(CCC)CCC

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.33
CHRM1 P11229 1/20 0.32
AKR1A1 P14550 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32
DRD3 P35462 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP3A4 P08684 1/20 0.30
NFKB1 P19838 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
FDPS P14324 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL241739 0.96 TSHR (0.32) TSHRCHRM1AKR1A1CHRM3HTR2A
Ethylene Glycol SCHEMBL22581580 0.87 TSHR (0.39) TSHRCHRM1AKR1A1CHRM3HTR2A
SCHEMBL2541482 0.87 DNM1 (0.39) TSHRTDP1CYP3A4FDPS
SCHEMBL267594 0.86 PRKCA (0.34) TSHR
SCHEMBL8380611 0.85 TSHR (0.38) TSHRCHRM1AKR1A1CHRM3HTR2A
SCHEMBL3797184 0.85 OPRM1 (0.42) TSHRFDPS
SCHEMBL11225910 0.85 TSHR (0.32) TSHR
SCHEMBL11084549 0.85
SCHEMBL19546012 0.83 PRKCA (0.33) TSHR
SCHEMBL20299937 0.83 LMNA (0.42) TSHRFDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119998977-A Electrolyte, battery cell, battery and electricity utilization device 宁德时代新能源科技股份有限公司 2025-05-13 CN claimed
CN-119725718-A Electrolyte, battery and electricity utilization device 宁德时代新能源科技股份有限公司 2025-03-28 CN claimed
CN-119725756-A Electrolyte, battery and electricity utilization device 宁德时代新能源科技股份有限公司 2025-03-28 CN claimed
CN-119452496-A Electrolyte, battery and electricity utilization device 宁德时代新能源科技股份有限公司 2025-02-14 CN claimed
CN-116960467-B Battery cell, battery and electricity utilization device 宁德时代新能源科技股份有限公司 2024-02-20 CN claimed
US-11840594-B2 Polymerization catalyst system and process to produce highly reactive polyisobutylene INDIAN OIL CORPORATION LIMITED (IN) 2023-12-12 US claimed
WO-2023232613-A1 PROCESS FOR MANUFACTURING OF HIGHER FUNCTIONAL POLYISOBUTENES BASF SE (DE) 2023-12-07 WO claimed
CN-116960467-A Battery cell, battery and electricity utilization device 宁德时代新能源科技股份有限公司 2023-10-27 CN claimed
CN-113968922-B Polymerization catalyst system and method for preparing high-reactivity polyisobutene 印度石油有限公司 2023-08-15 CN claimed
EP-3635807-B1 ELECTROLYTE FOR AN ALKALI METAL-SULFUR-BATTERY, ALKALI METAL-SULFUR-BATTERY CONTAINING THE SAME, AND USE OF THE ELECTROLYTE FRAUNHOFER GES FORSCHUNG (DE) 2022-04-20 EP claimed
CN-103210014-B Ionic polymers, method for producing same and use thereof GF生物化学有限公司 2016-08-10 CN claimed
US-20160031780-A1 ETHER BLENDS VIA REACTIVE DISTILLATION GASTECHNO CORP. 2016-02-04 US claimed
CN-104245788-A Poly (lactone), method for producing same, and use thereof SEGETIS INC 2014-12-24 CN claimed
WO-2014144099-A1 ETHER BLENDS VIA REACTIVE DISTILLATION GAS TECHNOLOGIES LLC (US) 2014-09-18 WO claimed
US-20140275634-A1 Ether Blends Via Reactive Distillation GAS TECHNOLOGIES LLC (US) 2014-09-18 US claimed
CN-103210014-A Ionic polymers, method for producing same and use thereof SEGETIS INC 2013-07-17 CN claimed
US-20080249149-A1 Crystalline Forms of Rizatriptan Benzoate RATIOPHARM GMBH (DE) 2008-10-09 US claimed
EP-1970397-A1 Hydrophilic Polysiloxane Elastomers Schering Oy (FI) 2008-09-17 EP claimed
EP-1709032-A2 CRYSTALLINE FORMS OF RIZATRIPTAN BENZOATE Ratiopharm GmbH (DE) 2006-10-11 EP claimed
WO-2005068453-A2 CRYSTALLINE FORMS OF RIZATRIPTAN BENZOATE RATIOPHARM GMBH (DE) 2005-07-28 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249149-A1 Crystalline Forms of Rizatriptan Benzoate CYP3A43, CYP2C9, CPA3 TSHR 2283/4885CHRM1 3815/4885AKR1A1 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.